196 related articles for article (PubMed ID: 32770860)
1. Prolonged acute generalized exanthematous pustulosis and atypical target-like lesions induced by hydroxychloroquine.
Otake-Irie H; Nakajima S; Okamoto N; Toichi E; Nomura T; Kabashima K
J Dermatol; 2020 Nov; 47(11):e387-e388. PubMed ID: 32770860
[No Abstract] [Full Text] [Related]
2. Acute generalized exanthematous pustulosis induced by hydroxychloroquine: a case with atypical clinical presentation.
Duman H; Topal IO; Kocaturk E; Cure K; Mansuroglu I
An Bras Dermatol; 2017; 92(3):404-406. PubMed ID: 29186260
[TBL] [Abstract][Full Text] [Related]
3. Acute generalized exanthematous pustulosis induced by hydroxychloroquine successfully treated with etretinate.
Matsuda-Hirose H; Sho Y; Yamate T; Nakamura Y; Saito K; Takeo N; Nishida H; Ishii K; Sugiura K; Hatano Y
J Dermatol; 2020 Feb; 47(2):e53-e54. PubMed ID: 31840277
[No Abstract] [Full Text] [Related]
4. Prolonged pustular eruption from hydroxychloroquine: an unusual case of acute generalized exanthematous pustulosis.
Pearson KC; Morrell DS; Runge SR; Jolly P
Cutis; 2016 Mar; 97(3):212-6. PubMed ID: 27023083
[TBL] [Abstract][Full Text] [Related]
5. The First Pediatric Case of Acute Generalized Exanthematous Pustulosis Caused by Hydroxychloroquine.
Liccioli G; Marrani E; Giani T; Simonini G; Barni S; Mori F
Pharmacology; 2019; 104(1-2):57-59. PubMed ID: 31067554
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporine for corticosteroid-refractory acute generalized exanthematous pustulosis due to hydroxychloroquine.
Castner NB; Harris JC; Motaparthi K
Dermatol Ther; 2018 Sep; 31(5):e12660. PubMed ID: 30152569
[TBL] [Abstract][Full Text] [Related]
7. [Acute generalized exanthematic pustulosis induced by hydroxychloroquine: case report].
Djennane M; Tablit I; Billhot M; Banal F
Rev Med Interne; 2010 Mar; 31(3):e7-8. PubMed ID: 20089332
[TBL] [Abstract][Full Text] [Related]
8. Acute generalized exanthematous pustulosis induced by empiric hydroxychloroquine for presumed COVID-19.
Enos T; Jeong HS; Vandergriff T; Jacobe HT; Chong BF
Dermatol Ther; 2020 Nov; 33(6):e13834. PubMed ID: 32542893
[No Abstract] [Full Text] [Related]
9. Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19.
Delaleu J; Deniau B; Battistella M; de Masson A; Bensaid B; Jachiet M; Lazaridou I; Bagot M; Bouaziz JD;
J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2777-2779.e1. PubMed ID: 32525093
[No Abstract] [Full Text] [Related]
10. [Acute cutaneous pustular eruption due to hydroxychloroquine].
Pastushenko I; Gracia-Cazaña T; Morales-Moya AL; Grasa MP
Med Clin (Barc); 2014 Oct; 143(7):e13. PubMed ID: 24908623
[No Abstract] [Full Text] [Related]
11. Hydroxychloroquine-induced acute generalized exanthematous pustulosis with positive patch-testing.
Charfi O; Kastalli S; Sahnoun R; Lakhoua G
Indian J Pharmacol; 2015; 47(6):693-4. PubMed ID: 26729969
[TBL] [Abstract][Full Text] [Related]
12. Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report.
Coleman I; Ruiz G; Brahmbhatt S; Ackerman L
J Med Case Rep; 2020 Nov; 14(1):210. PubMed ID: 33138853
[TBL] [Abstract][Full Text] [Related]
13. Initiation of hydroxychloroquine therapy during pregnancy can cause adverse effects and alter pregnancy outcomes: A case of acute generalised exanthematous pustulosis induced by hydroxychloroquine in a patient with systemic lupus erythematosus.
Tsurane K; Kaneko K; Yoshida K; Tanaka R; Sago H; Murashima A
Mod Rheumatol Case Rep; 2023 Jun; 7(2):373-377. PubMed ID: 36420890
[TBL] [Abstract][Full Text] [Related]
14. Acute generalized exanthematous pustulosis induced by generic hydroxychloroquine.
Wang G; Zhuo N; Li J
J Cosmet Dermatol; 2022 Aug; 21(8):3608-3610. PubMed ID: 34757679
[No Abstract] [Full Text] [Related]
15. Acute generalized exanthematous pustulosis induced by hydroxychloroquine: first case report in Canada and review of the literature.
Bailey K; McKee D; Wismer J; Shear N
J Cutan Med Surg; 2013; 17(6):414-8. PubMed ID: 24138979
[TBL] [Abstract][Full Text] [Related]
16. Acute generalized exanthematous pustulosis after COVID-19 treatment with hydroxychloroquine.
Litaiem N; Hajlaoui K; Karray M; Slouma M; Zeglaoui F
Dermatol Ther; 2020 Jul; 33(4):e13565. PubMed ID: 32401410
[No Abstract] [Full Text] [Related]
17. Acute generalized exanthematous pustulosis due to terbinafine.
Ross CL; Shevchenko A; Mollanazar NK; Hsu S; Motaparthi K
Dermatol Ther; 2018 Jul; 31(4):e12617. PubMed ID: 29786933
[TBL] [Abstract][Full Text] [Related]
18. Acute generalized exanthematous pustulosis induced by hydroxychloroquine.
Hsieh CH; Yao CA; Lo Y
Kaohsiung J Med Sci; 2021 Dec; 37(12):1122-1123. PubMed ID: 34390130
[No Abstract] [Full Text] [Related]
19. Acute generalized exanthematous pustulosis with erythema multiforme-like lesions induced by Hydroxychloroquine in a woman with coronavirus disease 2019 (COVID-19).
Robustelli Test E; Vezzoli P; Carugno A; Raponi F; Gianatti A; Rongioletti F; Sena P
J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):e457-e459. PubMed ID: 32386448
[No Abstract] [Full Text] [Related]
20. [Drugs associated with acute generalized exanthematic pustulosis].
Saissi EH; Beau-Salinas F; Jonville-Béra AP; Lorette G; Autret-Leca E;
Ann Dermatol Venereol; 2003; 130(6-7):612-8. PubMed ID: 13679697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
